Cargando…

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma

Detalles Bibliográficos
Autores principales:	Gammon, Joshua M, Jewell, Christopher M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652479/ http://dx.doi.org/10.1186/2051-1426-3-S2-P434

Ejemplares similares

Enhancing anti-tumor immunity through local gene delivery to lymph nodes
por: Dold, Neil M, et al.
Publicado: (2015)

Targeted Programming of the Lymph Node Environment Causes Evolution of Local and Systemic Immunity
por: Andorko, James I., et al.
Publicado: (2016)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
por: Broucek, Joseph, et al.
Publicado: (2014)

Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
por: Andorko, James I., et al.
Publicado: (2014)

Immune-cancer interactions in tumors and tumor-draining lymph nodes: Novel prognostic indicators for breast cancer
por: Mansfield, James, et al.
Publicado: (2014)

Molecular characterization of breast tumor cells in sentinel lymph nodes
por: Torresan, Clarissa, et al.
Publicado: (2013)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

CCL19-sorted mature dendritic cells have enhanced lymph node migratory capacity and function
por: Le Brocq, Michelle L, et al.
Publicado: (2015)

STING contributes to anti-glioma immunity via triggering type-I IFN signals in the tumor microenvironment
por: Ohkuri, Takayuki, et al.
Publicado: (2014)

Magnetic resonance spectroscopy of breast cancer tissue used for tumor classification and lymph node prediction
por: Sitter, B, et al.
Publicado: (2005)

Image directed lymph node sampling for lung cancer staging
por: Quint, Leslie E, et al.
Publicado: (2014)

Preoperative identification and biopsy of sentinel lymph nodes using contrast-enhanced ultrasound: the Tunbridge Wells experience
por: De'Silva, Tania, et al.
Publicado: (2015)

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients
por: Zirakzadeh, A Ali, et al.
Publicado: (2015)

Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
por: Antonios, Joseph, et al.
Publicado: (2015)

Risk factors for lymph node metastasis in patients with unifocal breast cancer
por: Robinson, A, et al.
Publicado: (2011)

Counteracting breast-cancer induced immune suppression by reactivating lymph node-resident conventional dendritic cells (LNR-cDC)
por: van de Ven, Rieneke, et al.
Publicado: (2015)

The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
por: Sansal-Castellano, Isabelle, et al.
Publicado: (2015)

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer
por: Heeren, Marijne, et al.
Publicado: (2014)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Bortezomib enhances anti-tumor T cell immunity by remodeling Notch system
por: Thounaojam, Menaka, et al.
Publicado: (2014)

Severe anaphylaxis during sentinel lymph node biopsy (SLNB)
por: Pinela, Andreia Ferrão Vasconcelos, et al.
Publicado: (2014)

How many sentinel lymph nodes should we excise?
por: Piechocki, J, et al.
Publicado: (2009)

Profiling of suppressive immune subsets in metastasis negative and positive sentinel lymph nodes from patients with HER2- breast cancer
por: van de Ven, Rieneke, et al.
Publicado: (2014)

Inflammation and Tumor Microenvironment in Lymph Node Metastasis
por: Wu, Xuesong, et al.
Publicado: (2011)

Sentinel lymph node biopsy in breast cancer: day surgery and local anaesthetic approach
por: Ricci, F, et al.
Publicado: (2009)

P1218: A REPROGRAMMING OF THE LYMPH NODE MICROENVIRONMENT UNDERLIES LOSS OF COMPARTMENTALISATION IN AGGRESSIVE LYMPHOMAS
por: Mathioudaki, Anna, et al.
Publicado: (2023)

Modelling of the impact of replacing four-node sampling with sentinel lymph node biopsy within the NHS Breast Screening Programme
por: Cheung, CS, et al.
Publicado: (2006)

Sentinel lymph node biopsy for breast cancer: how many nodes to stop at? Experience at a tertiary centre in Singapore
por: Pang, SYJ, et al.
Publicado: (2009)

Lymph node invasion by tumor cells modifies the distribution of dendritic cell subsets and memory T cell profiles in human cancer patients
por: Núñez, Nicolás Gonzalo, et al.
Publicado: (2014)

The impact of metabolic stress on anti-tumor immunity in laboratory mice
por: Kokolus, Kathleen M, et al.
Publicado: (2013)

Trp53 inactivation in the tumor microenvironment promotes tumor progression by enhancing pro-inflammatory tumor stromal populations
por: Guo, Gang, et al.
Publicado: (2013)

The impact of circulating regulatory T cells number and their subpopulations on risk of lymph node metastasis
por: Wydmanski, Jerzy, et al.
Publicado: (2015)

Lymph node metastases display gene expression profiles of their primary breast carcinomas
por: Weigelt, B, et al.
Publicado: (2005)

Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

Lymph node fibroblastic reticular cells steer immune responses
por: Li, Lushen, et al.
Publicado: (2021)

Cross talks between the immune and lymphatic endothelial cells regulate inflammatory lymph node lymphangiogenesis: defining a new therapeutic approach
por: Elhadad, Sonia
Publicado: (2013)

Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice
por: Foote, Jeremy, et al.
Publicado: (2015)

Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases
por: Zhou, Yuan, et al.
Publicado: (2021)

Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
por: Kwilas, Anna R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hsqdvp5bvu829jqt791tib3t4b